State-of-the Art Technologies
- Parental cell lines (CHO K1, CHO DG44, NS0, Sp2/0)
- Highly effective expression vectors (specifically designed to generate cell lines using CHO, NS0, and Sp2/0)
- Cell culture media and feeds (specially formulated for CHO, NS0, and Sp2/0, supports both fed-batch and continuous perfusion operation)
Extensive Expertise
- Cell line development, upstream, downstream, formulation, and analytical method development
- Biosimilar product development; achieving high yields while maintaining high biosimilarity
- Process scale-up, tech transfer, and GMP manufacturing
- Regulatory filing with FDA and EMA
Licensing opportunities
- Cell line development platforms
- Media and feeds
- Biosimilar products
Services
- GMP ready production cell lines and manufacturing process
- Comprehensive process development (upstream, downstream, formulation, and analytical), process scale-up, CMC and regulatory support
Partnership
- Co-development of biopharmaceutical products